Regado BioSciences Files $75 million IPO

Duke University spin-off Regado BioSciences has filed a $75 million initial public offering.

Regado Biosciences, Raises $51M

Regado Biosciences, which maintains a development lab in Durham, is developing drugs to control bleeding, and has raised $51 million in new financing, including backing from Triangle-based Aurora Funds.